Greg Fischer was Appointed as Interim Head of Finance at Arranta Bio

Date of management change: March 17, 2022 

What Happened?

Watertown, MA-based Arranta Bio Appointed Greg Fischer as Interim Head of Finance

 

About the Company

Arranta Bio is delivering on its vision to build the best-in-class microbiome contract development and manufacturing organization (CDMO) through our merger with a 10-year veteran CDMO, Captozyme, and the establishment of a commercial-ready manufacturing facility. We provide manufacturing and development support for live biotherapeutic products (LBPs) targeting gut health and microbiome-related diseases by providing development and manufacturing services that bring effective treatments to the market and patients in need.

 

About the Person

Greg Fischer is Interim Head of Finance at Arranta Bio. Previously, Greg held various senior HR leadership roles in the industry.

 

Info Source

News

 

imageShort Profile

 

Name: Greg Fischer

Title: Interim Head of Finance

Company: Arranta Bio

Industry: Biotechnology

imageCurrent Contact Info

 

Email: ************@arrantabio.com 

Phone:.*** 

To get full contact details, please sign in or

 
Your email is safe with us: see our privacy policy
 

Other IT executives who recently changed jobs as well: Jenness Chelan, Bell Ryan, Farlee Dave, Shenai Kam, Dinkins Robert, Wagner Mike, Michael Warny, O`Leary Angie, Greenwood Dave, Burnette Steve, John Couper

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.